Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)
Locatelli
M
M
Colleoni
M
M
Noberasco
C
C
Nolé
F
F
Orlando
L
L
Munzone
E
E
Peruzzotti
G
G
Goldhirsch
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D056486:Chemical and Drug Induced Liver Injury; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008111:Liver Function Tests; D008727:Methotrexate / Q000008:administration & dosage; D012189:Retrospective Studies; D018570:Risk Assessment
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate